These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23873104)

  • 21. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
    Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
    Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
    J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
    Lajin B; Alachkar A
    Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between NQO1 genetic polymorphism and risk of bladder cancer.
    Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
    Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
    Agúndez JA; García-Martín E; Martínez C; Benito-León J; Millán-Pascual J; Calleja P; Díaz-Sánchez M; Pisa D; Turpín-Fenoll L; Alonso-Navarro H; Ayuso-Peralta L; Torrecillas D; Plaza-Nieto JF; Jiménez-Jiménez FJ
    BMC Neurol; 2014 Apr; 14():87. PubMed ID: 24755231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
    Hemissi I; Ayed H; Naimi Z; Meddeb K; Ayadi M; Zouari S; Zaghbib S; Talbi E; Chebil M; Ouerhani S
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1819. PubMed ID: 34549902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
    Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
    Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
    Wang Z; Hu J; Zhong J
    DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
    Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
    Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
    Liu H; Zhang W; Deng XD; Ma Y; Liu Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
    Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
    Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors.
    Sarutipaiboon I; Settasatian N; Komanasin N; Kukongwiriyapan U; Sawanyawisuth K; Intharaphet P; Senthong V; Settasatian C
    Cardiovasc Toxicol; 2020 Apr; 20(2):176-189. PubMed ID: 31332605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
    Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
    Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
    Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
    PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
    Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
    Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
    Mandal RK; Nissar K; Mittal RD
    Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.